Skip to main content
    O

    Orthopediatrics Corp (KIDS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $22.57
    +0.32 (+1.44%)

    Market Cap: $572.85M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    61%(22/36)
    Avg Surprise
    -62.37%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.21
    Range$-0.25 - $-0.16
    6 analysts
    EPS RevisionsNo revisions (7d)
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.17-26.5%
    60d ago$-0.17-26.5%
    30d ago$-0.210.0%
    7d ago$-0.210.0%
    Current$-0.21
    Revenue Consensus
    $68M
    Range$68M - $69M
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.16
    Range$-0.21 - $-0.08
    4 analysts
    Revenue Consensus
    $72M
    Range$71M - $73M
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.16---
    Sep 26EST
    		-$-0.21---
    Jun 26
    Reported Aug 4
    		$-0.26$-0.31+16.13%Beat-136.4%
    Mar 26
    Reported Apr 30
    		$-0.42$-0.44+4.55%Beat-7.7%
    Dec 25
    Reported Feb 26
    		$-0.26$-0.37+29.73%Beat+10.3%
    Sep 25
    Reported Oct 28
    		$-0.24$-0.26+7.69%Beat-33.3%
    Jun 25
    Reported Aug 5
    		$-0.11N/A+60.71%Beat+52.2%
    Mar 25
    Reported May 7
    		$-0.39$-0.43+9.30%Beat-14.7%
    Dec 24
    Reported Mar 4
    		$-0.29$-0.26-12.97%Miss-26.1%
    Sep 24
    Reported Nov 6
    		$-0.18$-0.19+5.26%Beat-38.5%
    Jun 24
    Reported Aug 5
    		$-0.23$-0.26+11.54%Beat-21.1%
    Mar 24
    Reported May 6
    		$-0.34$-0.40+15.00%Beat-17.2%
    Dec 23
    Reported Mar 6
    		$-0.23$-0.28+17.86%Beat+34.3%
    Sep 23
    Reported Nov 6
    		$-0.13$-0.20+35.00%Beat-160.0%
    Jun 23
    Reported Jul 31
    		$-0.19$-0.20+5.00%Beat-11.8%
    Mar 23
    Reported May 1
    		$-0.29$-0.34+14.71%Beat+3.3%
    Dec 22
    Reported Feb 28
    		$-0.35$-0.25-40.00%Miss-45.8%
    Sep 22
    Reported Oct 31
    		$-0.05N/A+76.19%Beat+66.7%
    Jun 22
    Reported Aug 3
    		$-0.17$-0.18+5.56%Beat-54.5%
    Mar 22
    Reported May 4
    		$-0.30$-0.37+18.92%Beat-20.0%
    Dec 21
    Reported Mar 2
    		$-0.24$-0.30+20.00%Beat+67.1%
    Sep 21
    Reported Nov 3
    		$-0.15$-0.23+34.78%Beat+21.1%
    Jun 21
    Reported Aug 4
    		$-0.11N/A+66.67%Beat+77.6%
    Mar 21
    Reported May 5
    		$-0.25$-0.25+0.00%Beat+16.7%
    Dec 20
    Reported Mar 10
    		$-0.73$-0.27-170.37%Miss-151.7%
    Sep 20
    Reported Nov 4
    		$-0.19$-0.31+38.71%Beat+5.0%
    Jun 20
    Reported Aug 5
    		$-0.49$-0.38-28.95%Miss-188.2%
    Mar 20
    Reported May 5
    		$-0.30$-0.22-36.36%Miss-42.9%
    Dec 19
    Reported Mar 4
    		$-0.29$-0.22-31.82%Miss-52.6%
    Sep 19
    Reported Nov 7
    		$-0.20$-0.16-25.00%Miss-33.3%
    Jun 19
    Reported Aug 7
    		$-0.17$-0.08-112.50%Miss+19.0%
    Mar 19
    Reported May 8
    		$-0.21$-0.17-23.53%Miss+48.8%
    Dec 18
    Reported Mar 6
    		$-0.19$-0.19+0.00%Beat+95.0%
    Sep 18
    Reported Oct 31
    		$-0.15$-0.12-25.00%Miss-15.4%
    Jun 18
    Reported Aug 8
    		$-0.21$-0.15-40.00%Miss+8.7%
    Mar 18
    Reported May 14
    		$-0.41$-0.30-36.67%Miss-
    Dec 17
    Reported Mar 7
    		$-3.82$-0.17-2147.06%Miss-
    Sep 17
    Reported Oct 16
    		$-0.13$-0.12-8.33%Miss-
    Jun 17
    Reported Aug 10
    		$-0.23$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-19.13EV/EBITDAN/A
    Price/FCF-295.79xFCF Yield-0.34%
    Profitability
    Profit Margin-15.70%Operating Margin-5.77%
    ROE-11.40%ROIC-7.01%
    Financial Health
    Debt/Equity0.29xInterest Coverage-3.71x
    Current Ratio4.78xQuick Ratio2.17x
    Trading Statistics
    Beta0.99Avg Volume187.16K
    52-Week High$26.7452-Week Low$14.42

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$22.25
    SMA 20$22.31
    SMA 50$23.11
    SMA 200$19.17
    EMA 10$22.24
    EMA 20$22.33
    EMA 50$22.21
    EMA 200$20.23

    MACD

    Line: -0.12Signal: -0.14Hist: 0.02

    ADX

    ADX: 14.4+DI: 21.5-DI: 20.3

    Aroon & PSAR

    Aroon Up16.0
    Aroon DownN/A
    PSAR$21.26

    Bollinger Bands

    Upper Band$23.08
    Lower Band$21.54
    %B Position692%(Upper)
    Band Width0.67

    RSI (14-Day)

    Neutral
    52.0

    Momentum Oscillators

    Stoch %K53.4
    Stoch %D44.1
    Williams %R-29.9
    ROC (10d)4.1%
    Momentum0.88
    CCI (20d)76.7
    MFI (14d)52.2

    Volatility Measures

    ATR (14d)$0.79(3.5%)
    StdDev (20d)0.39
    Hist Vol28.8%(Moderate)

    Volume Flow

    VWAP$22.67
    OBV1.9M
    AD Line-913.7K
    CMF (20d)0.062

    Volume Metrics

    Avg Vol (20d)181.2K
    Vol Ratio1.1x
    VWMA (20d)$22.28

    Pivot Points

    R3$22.92
    R2$22.58
    R1$22.42
    Pivot Point$22.08
    S1$21.92
    S2$21.58
    S3$21.42

    Advanced Oscillators

    TSI-4.69
    Ultimate Osc45.5
    KST-38.78

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$70.51M$59.36M$61.60M$61.25M$61.08M$52.41M$52.67M$54.57M$52.80M$44.69M$37.61M$39.97M
    Cost of Revenue$18.14M$15.97M$16.50M$15.98M$17.06M$14.15M$17.10M$14.51M$12.00M$12.51M$10.90M$9.02M
    Gross Profit$52.37M$43.39M$45.11M$45.27M$44.02M$38.26M$35.56M$40.06M$40.80M$32.17M$26.71M$30.95M
    Operating Expenses$56.43M$51.73M$53.28M$54.70M$54.68M$49.24M$47.78M$45.63M$46.47M$41.90M$33.80M$35.46M
    R&D$2.33M$2.23M$2.26M$2.33M$2.16M$2.35M$2.92M$2.58M$2.54M$3.00M$2.92M$2.56M
    SG&A$32.81M$31.02M$29.95M$29.16M$30.44M$30.28M$24.43M$26.30M$27.33M$24.73M$19.06M$17.97M
    Operating Income$-4,068,000$-8,335,000$-8,172,000$-9,428,000$-10,657,000$-10,981,000$-14,055,000$-5,566,000$-5,666,000$-9,723,000$-8,066,000$-4,508,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$2.53M$2.10M$1.93M$1.82M$1.12M$1.13M$1.32M$3.63M$261,000$637,000$-303,000$21,000
    Income Before Tax$-6,929,000$-10,858,000$-9,763,000$-11,898,000$-7,064,000$-10,463,000$-16,409,000$-9,137,000$-6,047,000$-10,336,000$-6,903,000$-3,742,000
    Income Tax Expense$234,000$-171,000$340,000$-125,000$49,000$196,000$-340,000$-1,218,000$-18,000$-2,531,000$-212,000$849,000
    Net Income$-7,163,000$-10,687,000$-10,103,000$-11,773,000$-7,113,000$-10,659,000$-16,069,000$-7,919,000$-6,029,000$-7,805,000$-6,691,000$-4,591,000
    EBITDA$1.30M$-3,035,000$-2,229,000$-4,777,000$-778,000$-4,289,000$-11,097,000$-223,000$-1,007,000$-4,671,000$-2,019,000$549,000
    EBIT$-4,401,000$-8,756,000$-7,831,000$-10,076,000$-5,948,000$-9,337,000$-15,090,000$-5,503,000$-5,786,000$-9,699,000$-7,206,000$-3,721,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about KIDS

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    100.0%
    Active Awards
    0
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    KIDS Valuation and Fair Value

    P/E
    -19.1x
    P/FCF
    -295.8x
    P/B
    1.6x
    See GNG's fair value

    KIDS Profitability: Margins, ROIC and FCF

    Gross margin
    73.7%
    Operating margin
    -5.8%
    Net margin
    -15.7%
    ROIC
    -7.0%
    ROE
    -11.4%
    FCF margin
    -0.7%
    FCF yield
    -0.3%

    KIDS Competitors

    CompanyTicker
    CorMedix IncCRMD
    Prime Medicine, Inc. Common StockPRME
    Fulgent Genetics IncFLGT
    DBV TechnologiesDBVT
    Solid Biosciences LLCSLDB
    Sagimet Biosciences Inc. Series A Common StockSGMT
    Climb Bio IncCLYM
    Silence Therapeutics PLCSLN

    Sector: Healthcare

    KIDS Analyst Ratings

    Consensus
    Buy
    Analysts
    9
    Strong Buy
    3
    Buy
    5
    Hold
    1
    Sell
    0
    Strong Sell
    0

    KIDS Bull Case vs Bear Case

    Bull case

    • KIDS beat EPS estimates in 87.5% of its last 8 reported quarters.
    • KIDS grew quarterly revenue 15.4% year over year.
    • 88.9% of KIDS's analyst ratings are Buy or Strong Buy.

    Bear case

    • KIDS has a -15.7% net profit margin.

    KIDS Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    15.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.21
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 3 down

    Frequently Asked Questions About KIDS

    Does KIDS pay dividends?

    Orthopediatrics Corp (KIDS) does not currently pay a regular dividend.

    What is KIDS's market cap?

    Orthopediatrics Corp (KIDS) has a market capitalization of $572.85M with a current stock price of $22.57.

    Related stocks

    Sector: Healthcare

    All stocks starting with K

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In